Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

SurgePays (SURG) Shares Outstanding (Diluted Average) (2022 - 2025)

SurgePays' Shares Outstanding (Diluted Average) history spans 7 years, with the latest figure at $20.1 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $20.1 million for Q4 2025, up 5.05% from a year ago — trailing twelve months through Dec 2025 was $20.1 million (up 5.05% YoY), and the annual figure for FY2025 was $20.1 million, up 5.05%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $20.1 million at SurgePays, up from $19.8 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $20.1 million in Q4 2025 to a low of $12.1 million in Q1 2022.
  • The 4-year median for Shares Outstanding (Diluted Average) is $14.9 million (2023), against an average of $16.2 million.
  • The sharpest move saw Shares Outstanding (Diluted Average) soared 30.55% in 2024, then rose 4.74% in 2025.
  • Year by year, Shares Outstanding (Diluted Average) stood at $12.4 million in 2022, then rose by 20.39% to $14.9 million in 2023, then increased by 28.12% to $19.1 million in 2024, then increased by 5.05% to $20.1 million in 2025.
  • According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods came in at $20.1 million, $19.8 million, and $19.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.